Literature DB >> 27344056

Neonatal Kisspeptin is Steroid-Independently Required for Defeminisation and Peripubertal Kisspeptin-Induced Testosterone is Required for Masculinisation of the Brain: A Behavioural Study Using Kiss1 Knockout Rats.

S Nakamura1, Y Uenoyama2, K Ikegami2, M Dai1, Y Watanabe2, C Takahashi1, M Hirabayashi3, H Tsukamura2, K-I Maeda4.   

Abstract

Rodents show apparent sex differences in their sexual behaviours. The present study used Kiss1 knockout (KO) rats to evaluate the role of kisspeptin in the defeminisation/masculinisation of the brain mechanism that controls sexual behaviours. Castrated adult Kiss1 KO males treated with testosterone showed no male sexual behaviours but demonstrated the oestrogen-induced lordosis behaviours found in wild-type females. The sizes of some of the sexual dimorphic nuclei of Kiss1 KO male rats are similar to those of females. Plasma testosterone levels at embryonic day 18 and postnatal day 0 (PND0) in Kiss1 KO males were high, similar to wild-type males, indicating that perinatal testosterone is secreted in a kisspeptin-independent manner. Long-term exposure to testosterone from peripubertal to adult periods restored mounts and intromissions in KO males, suggesting that kisspeptin-dependent peripubertal testosterone secretion is required to masculinise the brain mechanism. This long-term testosterone treatment failed to abolish lordosis behaviours in KO males, whereas kisspeptin replacement at PND0 reduced lordosis quotients in Kiss1 KO males but not in KO females. These results suggest that kisspeptin itself is required to defeminise behaviour in the perinatal period, in cooperation with testosterone. Oestradiol benzoate treatment at PND0 suppressed lordosis quotients in Kiss1 KO rats, indicating that the mechanisms downstream of oestradiol work properly in the absence of kisspeptin. There was no significant difference in aromatase gene expression in the whole hypothalamus between Kiss1 KO and wild-type male rats at PND0. Taken together, the present study demonstrates that both perinatal kisspeptin and kisspeptin-independent testosterone are required for defeminisation of the brain, whereas kisspeptin-dependent testosterone during peripuberty to adulthood is needed for masculinisation of the brain in male rats.
© 2016 British Society for Neuroendocrinology.

Entities:  

Keywords:  androgen surge; organisational effect; perinatal period; sexual behaviour; sexual differentiation

Mesh:

Substances:

Year:  2016        PMID: 27344056     DOI: 10.1111/jne.12409

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  5 in total

1.  Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study.

Authors:  Mona Akad; Răzvan Socolov; Cristina Furnică; Roxana Covali; Catalina Daniela Stan; Eduard Crauciuc; Ioana Pavaleanu
Journal:  Medicina (Kaunas)       Date:  2022-06-08       Impact factor: 2.948

2.  The GnRH Antagonist Degarelix Suppresses Gonadotropin Secretion and Pituitary Sensitivity in Midgestation Sheep Fetuses.

Authors:  Rebecka Amodei; Sonnet S Jonker; William Whitler; Charles T Estill; Charles E Roselli
Journal:  Endocrinology       Date:  2022-02-01       Impact factor: 5.051

Review 3.  The roles of kisspeptin revisited: inside and outside the hypothalamus.

Authors:  Yoshihisa Uenoyama; Vutha Pheng; Hiroko Tsukamura; Kei-Ichiro Maeda
Journal:  J Reprod Dev       Date:  2016-07-29       Impact factor: 2.214

Review 4.  The Role of Kisspeptin in Female Reproduction.

Authors:  Sareh Zeydabadi Nejad; Fahimeh Ramezani Tehrani; Azita Zadeh-Vakili
Journal:  Int J Endocrinol Metab       Date:  2017-04-22

5.  Mating-induced increase in Kiss1 mRNA expression in the anteroventral periventricular nucleus prior to an increase in LH and testosterone release in male rats.

Authors:  Youki Watanabe; Kana Ikegami; Sho Nakamura; Yoshihisa Uenoyama; Hitoshi Ozawa; Kei-Ichiro Maeda; Hiroko Tsukamura; Naoko Inoue
Journal:  J Reprod Dev       Date:  2020-09-24       Impact factor: 2.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.